Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-19

Clinical Trial Update: Effect of Lifitegrast on Dry Eye Disease Signs and Symptoms [Phase 4]

View source ↗

Summary

This Phase 4 study evaluated lifitegrast for its effect on signs and symptoms of dry eye disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lifitegrast (lifitegrast)

Snippet

Sponsor: Lifelong Vision Foundation | Conditions: Dry Eye | Phase 4 | Status: COMPLETED